|
"tseng jeng sen"的相关文件
显示项目 11-35 / 56 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-05-12T05:59:04Z |
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Chin, Chun-Shih; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-04-14T23:27:39Z |
Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018
|
Tseng, Jeng Sen; CHUN-JU CHIANG; Chen, Kun Chieh; Zheng, Zhe Rong; Yang, Tsung Ying; Lee, Wen Chung; Hsu, Kuo Hsuan; Huang, Yen Hsiang; Liu, Tsang Wu; Hsia, Jiun Yi; Chang, Gee Chen |
| 臺大學術典藏 |
2021-11-29T06:35:37Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; YEN-TING LIN; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-29T03:24:02Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; WEI-YU LIAO; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T05:29:42Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T05:28:05Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T03:48:58Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-02T07:00:50Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; CHAO-CHI HO; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-09-14T23:18:48Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M (Scientific Reports, (2021), 11, 1, (12084), 10.1038/s41598-021-91657-7)
|
Huang, Yen Hsiang; Tseng, Jeng Sen; Hsu, Kuo Hsuan; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2021-07-30T01:35:39Z |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses
|
Su, Sheng-Fang; Liu, Chia-Hsin; Cheng, Chiou-Ling; Ho, Chao-Chi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Huei-Wen; Chang, Gee-Chen; SUNG-LIANG YU; Li, Ker-Chau |
| 臺大學術典藏 |
2021-07-30T01:33:54Z |
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients
|
Hsu, Kuo-Hsuan; Huang, Jing-Wen; Tseng, Jeng-Sen; Chen, Kuan-Wen; Weng, Yih-Chyang; SUNG-LIANG YU; Yang, Tsung-Ying; Huang, Yen-Hsiang; Chen, Jeremy J W; Chen, Kun-Chieh; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-30T01:32:10Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; SUNG-LIANG YU; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-30T01:04:05Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-15T05:32:06Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen Hsiang; Tseng, Jeng Sen; Hsu, Kuo Hsuan; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2021-07-15T05:31:53Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen Hsiang; Hung, Jen Yu; Ko, How Wen; Su, Po Lan; Lai, Chun Liang; Chang, Huang Chih; Hsia, Te Chun; Lin, Sheng Hao; Wu, Kuan Li; JUSTIN CHENG-TA YANG; Su, Wu Chou; Chu, Yi Chun; Wang, Chin Chou; WEI-YU LIAO; YEN-TING LIN; Lin, Ching Hsiung; Lin, Meng Chih; Hsu, Kuo Hsuan; Tseng, Jeng Sen; Yang, Tsung Ying; Chen, Kun Chieh; Lee, Mei Hsuan; SUNG-LIANG YU; CHAO-CHI HO; Chang, Gee Chen |
| 臺大學術典藏 |
2021-07-12T02:24:08Z |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses
|
SU, SHENG-FANG; Liu, Chia-Hsin; Cheng, Chiou-Ling; Ho, Chao-Chi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Huei-Wen; Chang, Gee-Chen; Yu, Sung-Liang; Li, Ker-Chau |
| 臺大學術典藏 |
2021-05-21T11:40:35Z |
Primary tumor radiotherapy during EGFR-TKI disease control improves survival of treatment Nave advanced EGFR-mutant lung adenocarcinoma patients
|
Hsu, Kuo Hsuan; Huang, Jing Wen; Tseng, Jeng Sen; KUAN-WEN CHEN; Weng, Yih Chyang; SUNG-LIANG YU; Yang, Tsung Ying; Huang, Yen Hsiang; Chen, Jeremy J.W.; Chen, Kun Chieh; Chang, Gee Chen |
| 國立成功大學 |
2021-04-30 |
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
|
Lee;Po-Hsin;Yang;Tsung-Ying;Chen;Kun-Chieh;Huang;Yen-Hsiang;Tseng, Jeng-Sen;Hsu;Kuo-Hsuan;Wu;Yu-Chen;Liu;Ko-Jiunn;Chang;Gee-Chen |
| 臺大學術典藏 |
2021-03-15T08:41:47Z |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
|
Chang, Gee-Chen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Huang, Yen-Hsiang;Su, Kang-Yi;Sung-Liang Yu;Tseng, Jeng-Sen; Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Huang, Yen-Hsiang; Su, Kang-Yi; SUNG-LIANG YU; Tseng, Jeng-Sen |
| 臺大學術典藏 |
2021-03-11T05:38:25Z |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
|
Chang, Gee-Chen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Huang, Yen-Hsiang;Kang-Yi Su;Yu, Sung-Liang;Tseng, Jeng-Sen; Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Huang, Yen-Hsiang; KANG-YI SU; Yu, Sung-Liang; Tseng, Jeng-Sen |
| 臺大學術典藏 |
2021-03-11T05:35:04Z |
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
|
Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Zheng, Zhe-Rong; Yang, Tsung-Ying; Chen, Kun-Chieh; Huang, Yen-Hsiang; KANG-YI SU; Yu, Sung-Liang; Chang, Gee-Chen |
| 國立交通大學 |
2020-07-01T05:22:11Z |
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma
|
Raghav, Lovely; Chang, Ya-Hsuan; Hsu, Yi-Chiung; Li, Yu-Cheng; Chen, Chih-Yi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chuang, Cheng-Yen; Lee, Mei-Hsuan; Wang, Chih-Liang; Chen, Huei-Wen; Yu, Sung-Liang; Su, Sheng-Fang; Yuan, Shin-Sheng; Chen, Jeremy J. W.; Ho, Shinn-Ying; Li, Ker-Chau; Yang, Pan-Chyr; Chang, Gee-Chen; Chen, Hsuan-Yu |
| 臺大學術典藏 |
2020-02-10T09:00:24Z |
Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma
|
Tseng, Jeng-Sen; Wang, Chih-Liang; Huang, Ming-Shyan; Chen, Chung-Yu; Chang, Cheng-Yu; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Wu, Chih-Wei; Yang, Cheng-Ta; Chen, Yuh-Min; Chang, Gee-Chen; MONG-HSUN TSAI |
| 臺大學術典藏 |
2020-02-10T09:00:24Z |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemona?ve patients with EGFR-mutant lung adenocarcinoma
|
MONG-HSUN TSAI; Chang, Gee-Chen; Chen, Hsuan-Yu; Chen, Jeremy Jw; Su, Kang-Yi; Yu, Sung-Liang; Tsai, Meen-Hsin; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Yu, Chong-Jen; Liao, Wei-Yu; Tsai, Chi-Ren |
| 臺大學術典藏 |
2020-02-10T09:00:23Z |
Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Chen, Jeremy J. W.; Chang, Gee-Chen; MONG-HSUN TSAI |
显示项目 11-35 / 56 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目
|
